Biologix showcased its leadership in hematology at the 8th International Lymphoma Conference (ILC8 2026), held from September 24–26, 2026, at the Hilton Jeddah, Saudi Arabia.
The conference brought together leading healthcare professionals, hematologists, oncologists, and experts in lymphomas and leukemias to exchange knowledge, explore the latest scientific advancements, and discuss evolving treatment strategies aimed at improving patient outcomes.
Our participation reflects our ongoing commitment to supporting scientific exchange, fostering meaningful collaborations, and contributing to advancements in patient care.
We look forward to building on these valuable discussions and continuing to support initiatives that drive progress in healthcare.
